POS1 COST-EFFECTIVENESS OF RISENDRONATE THERAPY COMPARED TO ALENDRONATE IN POST-MENOPAUSAL WOMEN AT HIGH RISK OF OSTEOPOROTIC FRACTURE- A TAIWAN ANALYSIS
Abstract
Authors
R Saadi R Burge N Ferko M Thompson
R Saadi R Burge N Ferko M Thompson
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now